Curetis Acquires Patents and Rights to Genetic Antibiotic Resistance and Susceptibility (GEAR) Database and Know-How from Siemens

News The agreement gives Curetis worldwide rights to the database and IP based on Next Generation Sequencing, enhancing the company's position in the area of genetic antimicrobial resistance biomarker testing. Contributed Author:  Curetis N.V. Topics:  Medical Diagnostics